Abstract: A topical nail treat may include a topical nail solution including flucytosine, clotrimazole, diclofenac and DMSO. The topical nails solution may be applied to nail surfaces to treat or prevent a nail infection. A gel or ointment may be applied to nails over the topical nail solution.

Abstract: A method of making a pharmaceutical composition for delivery to the lower respiratory tract via nebulization within a sterile diluent includes mixing dry powder ingredients including a beta agonist or anticholinergic and one or more additional ingredients to formulate a dry powder mixture for mixing with the sterile diluent.

Abstract: A joist assembly system that is structured for dynamic retrieval of components, dynamic and precise positioning and location of retrieved components, assembly of the components to form a joist, and delivery of the assembled joist. The joist assembly system has a plurality of material handling systems, a plurality of welding systems, and a rigging table system. The material handling systems are structured to load and position the components such as chords and webs onto the rigging table. The rigging table in turn supports the chords or webs. Subsequently, the plurality of welding systems weld the webs to the chords to form the joist.

Abstract: This invention predicts results for a media clip posted to a social media influencer channel by maintaining a database of results data for media clips where an influencer channel includes media clips that include unstructured data, and structured data, and then provide to a first machine learning model a first set of channel data, extracting a first set of features, predicting a value for the first target variable, providing to a second machine learning model a second set of channel data including a second selection of structured data, and the predicted value of the first target variable, extracting a second set of features, and predicting a value for the second target variable.

Abstract: This invention classifies an action that appears in a video clip by receiving a video clip for analysis, applying a convolutional neural network mechanism (CNN) to the frames in the clip to generate a 4D embedding tensor for each frame in the clip, applying a multi-resolution convolutional neural network mechanism (CNN) to each of the frames in the clip to generate a sequence of reduced resolution blocks, computing a kinematic attention weight that estimates the amount of motion in the block, applying the attention weights to the embedding tensors for each frame in a clip, to generate a weighted embedding tensor, or context, that represents all the frames in the clip, at the resolution, combining the contexts across all resolutions to generate a multi-resolution context, performing a 3D pooling to obtain a 1D feature vector and classifying a primary action of the video clip based on the feature vector.

Abstract: A method of making a pharmaceutical composition for delivery to the lower respiratory tract via nebulization within a sterile diluent includes mixing dry powder ingredients including a beta agonist or anticholinergic and one or more additional ingredients to formulate a dry powder mixture for mixing with the sterile diluent.

Abstract: A compounded capsule may include cannabidiol powder for combining with a solution, cream, gel, suspension or ointment for administration to a skin surface. The compounded capsule may also include xylitol powder.

Abstract: A computerized system for complying with critical infrastructure protection (“CIP”) standards concerning system configuration changes. The system can be used to automatically identify and track changes to computers on the network, improving system security and CIP compliance reporting. In certain embodiments, the system collects system information on servers and workstations using built-in commands. The configuration profiles of these computers/devices can be archived for audit purposes.

Abstract: The present application relates to compounded compositions, methods of making compounded compositions, and methods of using compounded compositions. For example, disclosed herein are compounded compositions and methods of making compounded compositions comprising one or more antimicrobial agents such as mupirocin.

Abstract: The present application relates to compounded compositions, methods of making compounded compositions, and methods of using compounded compositions. For example, disclosed herein are compounded compositions and methods of making compounded compositions comprising one or more anti-infective agents such as mupirocin.

Abstract: A method of compounding a topical cream includes combining ingredients including lidocaine and prilocaine, 2.5%/2.5%, cream, lidocaine hydrochloride, 4%, topical solution; and mixing the ingredients to generate a cream.

Abstract: A topical nail treat may include a topical nail solution including flucytosine, clotrimazole, diclofenac and DMSO. The topical nails solution may be applied to nail surfaces to treat or prevent a nail infection. A gel or ointment may be applied to nails over the topical nail solution.

Abstract: A method of powderizing a dry cake pharmaceutical drug product for injection within a vial may include securing a vial containing a dry cake pharmaceutical drug product for injection to a shaker device and powderizing the dry cake pharmaceutical drug product within the vial by shaking the vial with the shaker device operated at between about 100 to about 5000 cycles per minute for between about 10 minutes and about 1 hour.

Abstract: A method of managing non-infective nasal symptoms may include combining a steroid with a diluent, and acetylcysteine, azelastine, or theophylline. The combined ingredients may be mixed to formulate a topical composition for intranasal irrigation or nebulization. The steroid may include fluticasone, budesonide, or methylprednisolone.

Abstract: A method of compounding a topical cream includes combining ingredients including lidocaine hydrochloride, 4%, topical solution, diclofenac sodium, 1.5%, topical solution, lidocaine hydrochloride USP powder, and diclofenac sodium powder.

Abstract: A method of treating a hyperkeratotic skin condition includes combining contents of a compounded capsule with corticosteroid cream or ointment that includes a high potency corticosteroid to formulate a topical composition for application to a skin area affected by hyperkeratosis. The contents of the capsule may include urea powder, and the corticosteroid cream or ointment may include Clobetasol Propionate Cream or Ointment, Diflorasone Diacetate Cream or Ointment, Amcinonide Cream or Ointment, Betamethasone Dipropionate Cream or Ointment, Desoximetasone Cream or Ointment, Fluocinonide Cream or Ointment, Halcinonide Cream or Ointment, Halobetasol Propionate Cream or Ointment, Mometasone Furoate Cream or Ointment, Flurandrenolide Cream or Ointment, or a combination thereof.

Abstract: A method of treating a fungal infection may include formulating a topical treatment solution comprising combining itraconazole oral solution, 10 mg/mL, and a diluent. The itraconazole oral solution, 10 mg/mL, may include propylene glycol and at least one of cherry flavor or caramel flavor. The method may also include topically administering the topical treatment solution to the subject by contacting an infected skin surface of the subject with the topical treatment solution.

Abstract: A computerized system for complying with critical infrastructure protection (“CIP”) standards concerning system configuration changes. The system can be used to automatically identify and track changes to computers on the network, improving system security and CIP compliance reporting. In certain embodiments, the system collects system information on servers and workstations using built-in commands. The configuration profiles of these computers/devices can be archived for audit purposes.

Abstract: A method of making a pharmaceutical composition for delivery to the lower respiratory tract via nebulization within a sterile diluent includes mixing dry powder ingredients including a beta agonist or anticholinergic and one or more additional ingredients to formulate a dry powder mixture for mixing with the sterile diluent.

Abstract: A method of treating a bacterial infection of a subject includes topically administering a topical composition that includes nitrofurantoin combined with a carrier. The topical composition may be administered by contacting a tissue surface of the subject to be treated with the topical composition such as skin or mucosal tissue.